Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Therapies02:49

Cancer Therapies

10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

680
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
680

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing whole genome and transcriptome sequencing for cancer patients in routine healthcare: a comprehensive guide to costing.

British journal of cancer·2026
Same author

A Systemic Selective Modified mRNA Delivery Platform for Preventing Chemotherapy-Induced Cardiotoxicity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients.

BMC medicine·2026
Same author

The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regeneration.

Nature communications·2025
Same author

Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation.

Blood·2025
Same author

MetInfilt: A prospective trial highlighting the importance of the histological growth pattern in brain metastases.

Translational oncology·2025
Same journal

Implementing acute exacerbations of COPD care bundles: evidence, effectiveness and future directions.

European respiratory review : an official journal of the European Respiratory Society·2026
Same journal

Preclinical human models of primary ciliary dyskinesia.

European respiratory review : an official journal of the European Respiratory Society·2026
Same journal

Bench evidence, bedside uncertainty: hyperoxia, mechanical ventilation and lung injury.

European respiratory review : an official journal of the European Respiratory Society·2026
Same journal

Respiratory support in paediatric patients with bronchiolitis: a systematic review and meta-analysis.

European respiratory review : an official journal of the European Respiratory Society·2026
Same journal

Air pollution-induced airway epithelial barrier dysfunction in COPD: a narrative review of mechanisms and therapeutic implications.

European respiratory review : an official journal of the European Respiratory Society·2026
Same journal

Utilising human cellular models of primary ciliary dyskinesia: a scoping review.

European respiratory review : an official journal of the European Respiratory Society·2026
See all related articles

Related Experiment Video

Updated: Feb 27, 2026

Tracheotomy: A Method for Transplantation of Stem Cells to the Lung
03:45

Tracheotomy: A Method for Transplantation of Stem Cells to the Lung

Published on: February 25, 2007

12.3K

Cell therapy for lung disease.

Sabine Geiger1, Daniela Hirsch2, Felix G Hermann2

  • 1Preclinical Development, Apceth Biopharma GmbH, Munich, Germany f.hermann@apceth.com.

European Respiratory Review : an Official Journal of the European Respiratory Society
|June 30, 2017
PubMed
Summary
This summary is machine-generated.

Mesenchymal stem/stromal cells (MSC) show promise for treating lung disorders, offering anti-inflammatory and anti-fibrotic benefits. Both preclinical and clinical studies suggest MSC therapy is safe and effective for various lung diseases.

More Related Videos

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

14.4K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.4K

Related Experiment Videos

Last Updated: Feb 27, 2026

Tracheotomy: A Method for Transplantation of Stem Cells to the Lung
03:45

Tracheotomy: A Method for Transplantation of Stem Cells to the Lung

Published on: February 25, 2007

12.3K
Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

14.4K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.4K

Area of Science:

  • Regenerative Medicine
  • Pulmonology
  • Cell Therapy

Background:

  • Lung disorders are a major global cause of death, with limited effective treatments.
  • Cell therapies, particularly mesenchymal stem/stromal cells (MSC), offer novel therapeutic potential.
  • MSC possess inherent anti-inflammatory and anti-fibrotic properties beneficial for lung conditions.

Purpose of the Study:

  • To review preclinical and clinical evidence on MSC therapy for lung diseases.
  • To assess the efficacy and safety of MSCs in treating various pulmonary conditions.
  • To highlight MSCs as a promising therapeutic strategy for lung disorders.

Main Methods:

  • Review of preclinical studies in animal models of lung diseases.
  • Analysis of clinical trial data investigating MSC treatment in patients.
  • Synthesis of evidence on MSC efficacy, safety, and mechanisms of action.

Main Results:

  • Preclinical studies consistently show improved disease parameters after MSC administration.
  • Clinical studies indicate that MSC treatment is safe for patients with lung diseases.
  • MSC therapy has demonstrated potential in conditions like COPD, ARDS, and IPF.

Conclusions:

  • Mesenchymal stem/stromal cells represent a promising therapeutic avenue for lung diseases.
  • Current evidence supports the safety and potential efficacy of MSCs in pulmonary medicine.
  • Further research is essential to fully establish MSCs as a standard treatment for lung disorders.